NEW YORK (GenomeWeb News) – Foundation Medicine reported after the close of the market Wednesday that its third quarter revenues more than doubled year over year and were up 39 percent over the second quarter of this year.

The Cambridge, Mass.-based cancer genomic analysis firm reported total revenues of $8.2 million for the three months ended Sept. 30, up from $3 million in Q3 2012 and $5.9 million in Q2 2013. It beat the consensus Wall Street estimate for revenues of $6.9 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: self-assembly of DNA components in solution, and more.

Genetics and Molecular Research retracts two gastric cancer papers for being "substantially equal" to other papers, according to Retraction Watch.

A new analysis indicates that the Ebola virus behind the current West African outbreak is mutating at about the same rate as other Ebola viruses.

With the launch of Scott Kelly into space today, the study of him and his earthbound brother to disentangle the effects of life in space from the effects of genetics kicks off.

Apr
15
Sponsored by
WaferGen

This live online seminar will highlight recent trends in applying next-generation sequencing in the clinical setting, with a particular focus on oncology and rare disease.